Olive Oil
In clinical developmentAlso known as Clinolipid, OLEA EUROPAEA (OLIVE) FRUIT OIL, Sweet Oil, olive oil MISCELL OIL (ML)+1 more
Clinolipid, OLEA EUROPAEA (OLIVE) FRUIT OIL, Sweet Oil, olive oil MISCELL OIL (ML), olive oil@@MISCELL@OIL (ML).
Recent clinical, regulatory, research and industry developments relating to this drug.
Investigating N-3 Fatty Acids to Prevent Neonatal Tobacco-related outcomeS
Non-Surgical Treatment of Periodontitis in Menopausal Patients
Healthy Effects of Plant Polyphenols: Molecular Mechanisms.
Evaluation of the Efficacy and Safety of Indigo Naturalis Oil Extract on Psoriatic Nails
Effect of Omega-3 Fatty Acid on Vitamin D Activation in Hemodialysis Patients
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes4
Journals, researchers & institutions
- International journal of molecular sciences1
- Nutrients1
- Alarcón-de-la-Lastra C1
- Bucciantini M1
- Calabrese EJ1
- Calabrese V1
- Castañer O1
- Delgado-Rodríguez M1
- Fitó M1
- Gaforio JJ1
- Catalan Institute of Oncology1
- Center for Advanced Studies in Olive Grove and Olive Oils1
- Centre for Exercise1
- Department of Experimental and Clinical Biomedical Sciences "Mario Serio"1
- Girona Biomedical Research Institute (IDIBGI)1
- Harvard TH Chan School of Public Health1
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials